PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway
Weirong Wang(Xi'an Jiaotong University), Yanxiang Li(Shandong University), Qinqin Lin(Xi'an Jiaotong University), Jiye Zhang(Xi'an Jiaotong University), Rong Lin(Nanjing University of Chinese Medicine), Meixi Ji(Xi'an Jiaotong University), Feng Ren(Xi'an Jiaotong University), Jianfeng Zhang(Xi'an Jiaotong University)
Cited by 48
Related Papers
Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021
|Journal of Hematology & Oncology|2024|287
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight/obese polycystic ovary syndrome
|Clinical Endocrinology|2017|140
Suppression of <scp>SPIN1</scp>‐mediated <scp>PI3K</scp>–Akt pathway by <scp>miR</scp>‐489 increases chemosensitivity in breast cancer
|The Journal of Pathology|2016|121